Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

CCR2 Receptor Ligands Inhibit Cav3.2 T-Type Calcium Channels

Haitao You, Christophe Altier and Gerald W Zamponi
Molecular Pharmacology February 2010, 77 (2) 211-217; DOI: https://doi.org/10.1124/mol.109.059022
Haitao You
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christophe Altier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerald W Zamponi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 77 no. 2 211-217
DOI 
https://doi.org/10.1124/mol.109.059022
PubMed 
19864434

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received June 30, 2009
  • Accepted October 28, 2009
  • Published online January 19, 2010.

Article Versions

  • Earlier version (October 28, 2009 - 07:17).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2010 The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Haitao You,
  2. Christophe Altier and
  3. Gerald W Zamponi
  1. Department of Physiology and Pharmacology, Hotchkiss Brain Institute, University of Calgary, Calgary, Canada
  1. Address correspondence to:
    Dr. Gerald W. Zamponi, Department of Physiology and Pharmacology, University of Calgary, 3330 Hospital Dr. NW, Calgary, AB, T2N 4N1, Canada. E-mail: zamponi{at}ucalgary.ca
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: October 2009 to April 2022

AbstractFullPdf
Oct 200934024
Nov 2009620100
Dec 200974056
Jan 201028218185
Feb 20103192249
Mar 20101262743
Apr 2010862725
May 20101234025
Jun 20108732824
Jul 2010431820
Aug 201096169
Sep 20101423815
Oct 2010933417
Nov 2010242517
Dec 2010733114
Jan 2011502212
Feb 201116615225
Mar 2011817522
Apr 2011252415
May 2011466831
Jun 2011312622
Jul 2011191629
Aug 2011343421
Sep 2011192118
Oct 2011261524
Nov 2011191318
Dec 2011211520
Jan 2012242320
Feb 2012223128
Mar 2012212546
Apr 2012227922
May 2012213321
Jun 2012142528
Jul 2012272625
Aug 2012302228
Sep 2012221814
Oct 2012251922
Nov 2012271714
Dec 2012351928
Jan 2013453536
Feb 2013312717
Mar 2013352622
Apr 2013182321
May 2013162023
Jun 2013161115
Jul 2013679
Aug 2013141111
Sep 201316103
Oct 20131598
Nov 2013171911
Dec 2013876
Jan 201421126
Feb 201414912
Mar 201462330
Apr 2014101618
May 201411313
Jun 20149176
Jul 2014151412
Aug 2014897
Sep 20141422
Oct 201411144
Nov 20141875
Dec 20148179
Jan 201591915
Feb 20154914
Mar 20151618526
Apr 201554141008
May 201541178
Jun 2015111513
Jul 2015181621
Aug 2015171111
Sep 2015881
Oct 2015275
Nov 20157104
Dec 20156664
Jan 20161127
Feb 20161498
Mar 201614810
Apr 2016554
May 20161043
Jun 201611105
Jul 2016368
Aug 201611107
Sep 2016725
Oct 2016273
Nov 20165108
Dec 20160117
Jan 201701614
Feb 201701811
Mar 201703019
Apr 201701017
May 201701634
Jun 201711611
Jul 20171113
Aug 20174142
Sep 20170134
Oct 20170124
Nov 201712510
Dec 20171258
Jan 20181187
Feb 20181134
Mar 20180194
Apr 20180174
May 20180287
Jun 20180541
Jul 20180196
Aug 20180173
Sep 20180168
Oct 20181104
Nov 20180101
Dec 2018967
Jan 20191454
Feb 2019732
Mar 20191533
Apr 2019520
May 20191307
Jun 20191017
Jul 20191962
Aug 20191111
Sep 2019711
Oct 20191201
Nov 20191222
Dec 20191233
Jan 2020811
Feb 2020900
Mar 20201033
Apr 2020220
May 2020652
Jun 20201521
Jul 20201220
Aug 2020314
Sep 2020600
Oct 2020414
Nov 2020712
Dec 2020910
Jan 20211853
Feb 20211515
Mar 20211725
Apr 20211934
May 20214824
Jun 20211541
Jul 20211011
Aug 20211736
Sep 2021820
Oct 20212041
Nov 20212153
Dec 20212421
Jan 20222212
Feb 20221412
Mar 2022710
Apr 20221232

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 77 (2)
Molecular Pharmacology
Vol. 77, Issue 2
1 Feb 2010
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
CCR2 Receptor Ligands Inhibit Cav3.2 T-Type Calcium Channels
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

CCR2 Receptor Ligands Inhibit Cav3.2 T-Type Calcium Channels

Haitao You, Christophe Altier and Gerald W Zamponi
Molecular Pharmacology February 1, 2010, 77 (2) 211-217; DOI: https://doi.org/10.1124/mol.109.059022

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

CCR2 Receptor Ligands Inhibit Cav3.2 T-Type Calcium Channels

Haitao You, Christophe Altier and Gerald W Zamponi
Molecular Pharmacology February 1, 2010, 77 (2) 211-217; DOI: https://doi.org/10.1124/mol.109.059022
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Therapeutic Effects of FGF23 Antagonists in Hyp Mice
  • TRPV3 and TRPV4 Channels Coassemble into Heterotetramers
  • Secretin Amino-Terminal Structure-Activity Relationships and Complementary Mutagenesis at the Site of Docking to the Secretin Receptor
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics